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Introduction
Tissue diagnosis of a musculoskeletal tumour mass is of
paramount importance, as these masses are based on
history, laboratory and radiological imaging. Ideally,
biopsyis meant to obtain a representative tissue with
minimal tumour spread and no interference to future
treatment and limb salvage procedures.1,2 Various
techniques, including open surgical biopsy, percutaneous
curette biopsy, core biopsy and fine needle aspiration
(FNA) have their own specific advantages and caveats.3
Open biopsy has long been known to be the gold
standard for diagnosis of tumours with about 94% to 95%
diagnostic accuracy.4
FNA is minimally invasive, has low risk of contamination
and is low-cost, but limited sample is a caveat.
Advantages of curette biopsies are that they are easily
done at clinic under local anaesthesia with good
diagnostic accuracy and is very cost-effective.5 Open
biopsies performed in operating rooms are done under
general anaesthesia and deep tissues, including those
which are close to major vessels, can be sampled.
Additional advantage is that the sample can be sent to
histopathology for frozen sections to confirm the tumour
cells in the acquired sample.6
The current study was planned to analyse and compare
the diagnostic accuracy of percutaneous curette biopsy at
clinic and open biopsy in extremity tumours.
Material and Methods
The retrospective study was conducted at Aga Khan
University Hospital (AKUH), Karachi, and comprised
record of patients who underwent biopsy procedure of
extremity tumours from January 2008 to December 2011.
Patients were identified from departmental tumour
registry and Health Information Management System
(HIMS).
All biopsies had been performed by a consultant
orthopaedic oncologist. Inclusion criteria for clinic
biopsies were adult patients over 18 years of age,
cooperative and able to tolerate the procedure under
local anaesthesia. Paediatric patients or patients with
cognitive impairments or phobic to proceed in clinic
under local anaesthesia, deep specimens involving pelvic
region or inaccessible mass or tissues close to major
vessels were excluded. These biopsies were subsequently
conducted in the operating room under general
anaesthesia.
For open biopsies, the obtained tissues were sent to
histopathology for frozen sections to confirm the
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Abstract
Objective: To compare the diagnostic accuracy of clinic-based biopsy versus theatre biopsy against final
histopathology in patients presenting with extremity tumours.
Methods: The retrospective study was conducted at Aga Khan University Hospital, Karachi, and comprised record
of patients who underwent biopsy procedure of extremity tumours from January 2008 to December 2011. Data
regarding socio-demographic status, disease-related and procedure-related variables were collected from the files.
Histopathology report of biopsy was compared with the final histopathology after definite procedure of the tumour
for concordance.
Results:Of the 87 patients whose records were reviewed, 42(48%) had undergone biopsy in theatre and 45(52%) in
clinic. The overall median age was 29 years (Inter-quartile range: 18-58 years). As compared to final histopathology
after the definite procedure, diagnostic accuracy of theatre and clinic-based biopsy was 97.7% vs. 95.5%
respectively. Surgical site infection was observed in 2(5%) in theatre and in 1(2.2%) in clinic.
Conclusion: Clinic-based biopsy was accurate and safe with diagnostic accuracy comparable to theatre-based
biopsy. Clinic-based biopsy, being cost-efficient along with low morbidity, should be preferred in patients with
extremity tumours.
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suspected pathology.
Clinical parameters in terms of age, gender, site and tissue
involvement, grade of lesion, and complications were
evaluated. Hitopathological reports of clinic as well
theatre biopsies were compared with the final
histopathological report of resected specimens to identify
concordance.
Results
Medical records of 119 patients were located, but 32(27%)
had to be excluded owing to insufficient or missing
information or because the final procedure had been
done elsewhere. The final study sample was 87(73%). Of
them, 42(48%) biopsieswere done in theatre and 45(52%)
in clinic.
In the theatres, themost common tumour was osteogenic
sarcoma in 11(26%) followed by Ewings tumour in 5(12%),
Giant cell tumour in 3(7%), while the rest included
Synovial sarcoma, malignant fibrous histiocytoma (MFH),
chondrosarcoma, lipo-myosarcoma, metastatic tumour
etc (Table 1). Biopsy was inconclusive in 1 patient, leaving
the diagnostic accuracy to be 97.7%.
Most common tumour in clinic was synovial sarcoma
found in 8(18%) followed by osteogenic sarcoma in
6(14%), Ewings tumour in 6(14%), and fibromyxoid
sarcoma in 3(6%) patients, while the rest included MFH,
chondrosarcoma, lipo-myosarcoma, metastatic tumour
etc. Biopsy was inconclusive in 3 patients, leaving the
diagnostic accuracy to be 95.5% (Table-2).
Three patients with inconclusive clinic biopsies
subsequently underwent re-biopsy in theatre of which
histopathological diagnosis of 2 patients could not be
established.
Complications encountered were surgical site infection
(SSI) in 2 patients operated in theatre and 1 patient whose
biopsy was performed in clinic which was managed
successfully by antibiotics. No other complications were
encountered.
Discussion
For a long time, open biopsy has been considered the
gold standard for biopsy and tissue diagnosis of
musculoskeletal masses. However, recent studies confirm
that the yield of biopsy is effective and should replace
open biopsy as the method of choice.7
Our study has quite comparable results in both biopsy
methods with the diagnostic accuracy of 97.7% in theatre
biopsies compared to 95.5% in clinic biopsies. We found 2
patients in whose biopsy were done in clinic to be
inconclusive. All of them were re-biopsied in the
operating room and unfortunately one of them failed to
get the tissue diagnosed.8
Mesenchymal tumours or sarcomas are difficult to
diagnose and need visualising the stromal structure in
addition to cellular morphology.9 Open biopsy has the
advantage of sending the specimen for frozen section
which makes sure that the representative samples must
be taken. Further, as sarcoma enlarge they outgrow their
blood supply, leading to area of central necrosis and
sampling from these zones can cause inconclusive
sampling.10
Conclusion
Clinic-based biopsy was accurate and safe with diagnostic
accuracy comparable to theatre-based biopsy. Clinic-
based biopsy, being cost-efficient along with low
morbidity, should be preferred in patients with extremity
tumours.
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Table-1: Patient characteristics.
Demographic variables Biopsy in clinic (n=42) Biopsy in theatre
(n=45)
Age 29 32±19.6
Gender Male/Female 53/47 60/40
Upper extremity (in %) 27 83
Lower extremity (in %) 73 17
Soft tissue tumour (in %) 69 26
Bone tumour (in %) 31 74
Most common tumour Synovial sarcoma Osteosarcoma
Table-2: Diagnostic accuracy as compared to final histopathology.
Diagnostic Yield Clinic biopsy Theatre biopsy
93 % 95%
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